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Abstract
Background: Chagas’ disease is an important neglected public health problem in many Latin American countries, but
population-based epidemiological data are scarce. Here we present a nationwide analysis on Chagas-associated mortality,
and risk factors for death from this disease.
Methodology/Principal Findings: We analyzed all death certificates of individuals who died between 1999 and 2007 in
Brazil, based on the nationwide Mortality Information System (a total of 243 data sets with about 9 million entries). Chagas’
disease was mentioned in 53,930 (0.6%) of death certificates, with 44,537 (82.6%) as an underlying cause and 9,387 (17.4%)
as an associated cause of death. Acute Chagas’ disease was responsible for 2.8% of deaths. The mean standardized mortality
rate was 3.36/100.000 inhabitants/year. Nationwide standardized mortality rates reduced gradually, from 3.78 (1999) to 2.78
(2007) deaths/year per 100,000 inhabitants (226.4%). Standardized mortality rates were highest in the Central-West region,
ranging from 15.23 in 1999 to 9.46 in 2007 (237.9%), with a significant negative linear trend (p = 0.001; R2 = 82%).
Proportional mortality considering multiple causes of death was 0.60%. The Central-West showed highest proportional
mortality among regions (2.17%), with a significant linear negative trend, from 2.28% to 1.90% (219.5%; p = 0.001;
R2 = 84%). There was a significant increase in the Northeast of 38.5% (p= 0.006; R2 = 82%). Bivariable analysis on risk factors
for death from Chagas’ disease showed highest relative risks (RR) in older age groups (RR: 10.03; 95% CI: 9.40–10.70;
p,0.001) and those residing in the Central-West region (RR: 15.01; 95% CI: 3.90–16.22; p,0.001). In logistic regression
analysis, age$30 years (adjusted OR: 10.81; 95% CI: 10.03–10.65; p,0.001) and residence in one of the three high risk states
Minas Gerais, Goia´s or the Federal District (adjusted OR: 5.12; 95% CI: 5.03–5.22, p,0.001) maintained important
independent risk factors for death by Chagas’ disease.
Conclusions/Significance: This is the first nationwide population-based study on Chagas mortality in Brazil, considering
multiple causes of death. Despite the decline of mortality associated with Chagas’ disease in Brazil, the disease remains a
serious public health problem with marked regional differences.
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Introduction
American trypanosomiasis (Chagas’ disease) is an anthropozoo-
nic vector-borne parasitic infection caused by the protozoan
parasite Trypanosoma cruzi [1–4]. Other important infection routes
include blood transfusion, vertical transmission, organ transplan-
tation, and oral transmission [1,2]. There are acute (often
asymptomatic) and chronic phases of the disease. In the case of
untreated acute disease, the infection may persist for many years
and even decades. Chronic disease manifests as indeterminate,
cardiac, gastrointestinal and neural forms [2]. As a chronic
condition, the infection may be associated with other chronic
diseases further increasing mortality [5].
Chagas’ disease is the sixth most important tropical infection in
the world in terms of global burden of disease [6], with high social
and economic impact throughout the endemic area [7–9]. Chronic
Chagas’ disease is a public health problem faced by many Latin
American countries, from Mexico in the north to Argentina in the
south. There are about 15 to 18 million people infected in Latin
America, and approximately 100 million are at potential risk for
infection [3,8]. An estimated 14,000 people die from the disease
each year worldwide [3]. Single autochthonous cases were notified
in the southern United States, but thousands are estimated [4,10].
Chronic cardiac disease is the leading cause of disability-
adjusted life years (DALYs) lost in young economically active
adults in endemic countries, with considerable social, public health
and economic consequences [2]. The migration of infected
individuals to non-endemic countries has become an emerging
public health problem in these regions, mainly in the United States
and European countries [3]. The principal means of transmission
in these countries are from blood transfusion, organ transplanta-
tion and mother-to-child transmission [11].
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In Brazil, the number of new Chagas’ disease cases has been
reduced dramatically in recent years, owing mainly to reduction of
vector transmission (mostly by the kissing bug Triatoma infestans)
and control of infection by blood transfusion [8–11]. However,
there is still a plethora of people living with chronic forms of the
disease. About 2 to 3 million people are estimated to be infected in
Brazil [7,12], 600,000 of them with chronic heart or digestive
complications, causing death in about 5,000 individuals each year
[13].
Despite the importance for health policy and planning,
mortality statistics from endemic countries have not yet been used
systematically to assess the impact of control measures against
Chagas’ disease [14]. To fill this gap, we present the first Brazilian
nationwide population-based study on Chagas mortality, using
multiple causes of death, as available on death certificates. We
analyzed mortality trends over time, geographical regions mostly
affected, and factors associated with the occurrence of death
caused by Chagas’ disease.
Methods
Study area and data sources
Brazil has a population of approximately 190 million inhabi-
tants. The country is divided into 26 States and one Federal
District. The Federation is further grouped into five major regions
(North, Northeast, Southeast, South and Central-West) with
different geographic, economic and cultural characteristics.
We analyzed all death certificates of individuals who died
between 1999 and 2007 in Brazil. As data source we used the
Brazilian death certificates, standardized by the Mortality
Information System (Sistema de Informac¸a˜o de Mortalidade - SIM) of
the Ministry of Health, a national electronic database. SIM data
are public domain and were obtained from the website of the
Department of the Unified Health System, DATASUS (http://
tabnet.datasus.gov.br/tabdata/sim/dados/cid10_indice.htm). Death
certificates contain demographic (age, gender, education, race,
marital status, municipality of residence and municipality of
occurrence of death) and clinical information (underlying and
associated causes of death). It is the physicians’ responsibility to
complete the death certificate forms. Until 1995, reference codes
were based on the International Classification of Diseases (ICD) in its
9th revision, and after 1996 in its 10th revision [15].
We identified Chagas-related deaths using category B57
(‘‘Chagas’ disease’’) including all subcategories (B57.0 to B57.5)
which represent both acute and chronic clinical forms, according
to the Tenth Revision of the International Statistical Classification
of Diseases and Related Health Problems (ICD-10) [15].
Population estimates were obtained from the Brazilian Institute
of Geography and Statistics (Instituto Brasileiro de Geografia e Estatı´stica
- IBGE) based on a national population census in 2000 and yearly
official estimates (1999–2007). The census is a fundamental source
of information from the entire Brazilian population, and data
collection and analysis are subject to supervision and quality
control.
This study was based on publicly available secondary anony-
mous data, with no possibility of identification of individuals.
Thus, approvement of the study by a Ethical Review Board was
not necessary.
Data processing and analysis
A total 243 data sets with about 9 million entries were
downloaded and processed (one data set for each of the 27 federal
states and each of the 9 years, from 1999–2007). In a first step, we
checked data sets for completeness in relation to the total number
of deaths. Field codes from different data sets were standardized
and variables not considered in the analysis eliminated. We then
identified all death certificates in which Chagas’ disease was
recorded in any line of the certificate as cause of death (both
underlying and associated causes). We created new variables for
causes of death, as in many cases more than one cause was noted
in a line.
Then, Chagas-related mortality rates for multiple causes of
death and underlying causes of death from 1999–2007 were
calculated. These mortality rates were calculated by dividing the
number of deaths in each calendar year by the population, and
presented per 100,000. We calculated the standardization of
mortality rates by age using the direct method, considering the
Brazilian population in 2003 as standard [16]. The proportional
mortality rate was calculated by dividing the number of deaths
from Chagas’ disease by the total number of deaths multiplied by
100. We present standardized specific mortality and proportional
mortality rates, stratified by region of residence, year of occurrence
of death, and age group. Mortality analysis in this study focuses on
multiple causes of death (including both underlying and any other
causes), and on the usual approach of underlying causes of death
(the disease or condition, which led directly to the death) [16].
Analysis of time trends of mortality rates was performed using
polynomial regression models. The polynomial model aimed to
find the curve that would best fit the data in order to describe the
relationship between the dependent variable (mortality associated
with Chagas’ disease) and the independent variable (year of death).
We first made scatter diagrams of indicators of mortality and the
years of death, to visualize the mathematical function that would
best represent the relationship between variables. From this
observation, we estimated the regression models. We tested the
following regression models where the values of Y and X are the
dependent and independent variables respectively and b0, b1, b2
and b3 are the coefficients of regression [15]: a) linear (1st order):
Y =b0+b1X; b) 2nd order: Y = b0+b1X+b2X2; c) third order:
Author Summary
American trypanosomiasis (Chagas’ disease) is a parasitic
disease which remains a public health problem in Latin
America, but studies investigating the dynamics in
populations under risk are scarce. We conducted a
nation-wide study based on about 9 million Brazilian
death certificates from 1999–2007. Epidemiological char-
acteristics of Chagas-related deaths, temporal trends and
associated factors were investigated. Chagas’ disease was
mentioned in about 54,000 (0.6%) death certificates,
resulting in a mean standardized mortality rate of 3.36/
100,000 inhabitants/year. Nationwide mortality rates re-
duced gradually, from 3.78 (1999) to 2.78 (2007) deaths/
year/100,000 inhabitants (226.4%). The vast majority of
deaths (97.2%) were caused by chronic form of the disease.
There were marked regional differences: mortality rates
were highest in the Central-West region. In contrast to the
rest of the country, there was a significant increase in the
Northeast (38.5%). Risk factors independently associated
with Chagas mortality were age .30 years (adjusted
OR= 10.60; 9.90–11.33, p,0.001) and residing in the states
of Minas Gerais, Goia´s or Federal District (adjusted
OR= 4.89, 4.81–4.98, p,0.001). We performed the first
nationwide population-based study on Chagas mortality,
considering multiple causes of death in Brazil. A compre-
hensive overview of mortality associated with Chagas’
disease is provided. Chagas’ disease is still a major public
health problem in the country.
Chagas Mortality in Brazil
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Y = b0+b1X+b2X2+b3X3; d) exponential: Y = eb0+b1X. The choice
of the best-fitting model was based on an analysis of the diagram,
the coefficient of determination (R2), the statistical significance and
residual analysis (true homoscedasticity assumption). When the
trend was not statistically significant, the model was chosen
according to the coefficient of determination and when two models
were similar, the statistical point of view, we chose the simplest
model (lowest order). Trends were considered statistically
significant when the models showed p,0.05.
We further performed bivariable and multivariable analysis to
identify association between demographic variables available
(gender, age, race, state and region of residence, residence in
state capital, year of death) and death due to Chagas’ disease. We
calculated relative risks (RR) with their respective 95% confidence
intervals and applied the chi-squared test to estimate significance
of the differences between relative frequencies. In logistic
regression analysis the variables included were gender, age $30
years, and residence in a high risk state Minas Gerais, Goia´s or
Federal District. The cut-off point of 30 years was based on the
natural history of the disease and disease control measures
implemented in the 1970s and 1980s [1,9–13]. Region of
residence and place of occurrence were excluded due to
collinearity with the variable on high risk states included. The
information on race/color lacked information in more than 10%
of cases and was thus not included; in addition, information on
skin color is not standardized in Brazil, and interpretation of this
variable is limited.
Calculation of the indicators and the preparation of tables and
figures were performed in Microsoft Excel spreadsheets. We used
SPSS for Windows version 15.0 (Statistical Package for the Social
Sciences; SPSS Corporation, Chicago, USA) for calculation of
polynomial regression models. Bivariable and multivariable
statistical analysis was performed using the programs STATA
version 11 (Stata Corporation, College Station, USA) and Epi Info
for Windows version 3.5.1 (Centers for Disease Control and
Prevention, Atlanta, USA).
Results
Of the 8,942,217 deaths occurring in Brazil between 1999 and
2007, acute or chronic Chagas’ disease was mentioned in 53,930
(0.6%) cases in any part of the death certificates, with 44,543
(82.6%) as an underlying cause and 9,387 (17.4%) as an associated
cause of death. The resulting mean standardized mortality rate
related to Chagas’ disease considering all fields of the death
certificates was 3.36/100,000 inhabitants/years. This is 21%
higher than the mortality rate considering merely underlying cause
of death (2.78 deaths/100,000 inhabitants/year). The mean
number of deaths related to Chagas’ disease was 5,992 per year,
ranging from 5,573 in 1999 to 6,227 in 2006.
Chronic forms (B57.2–B57.5) were identified in the vast
majority of deaths (n = 43,302; 97.2%). Deaths related to acute
Chagas’ disease (B57.0 and B57.1) represented only 2.8%
(n = 1,241), but increased by 24.4% in the study period. Death
due to acute Chagas’ disease was most common in the North
(Amazon) region of the country (11%; n = 64/581).
Individuals who died from Chagas’ disease were predominant-
ly males (57%), aged .60 years (62.8%) and residents in the
Southeast region (53.6%). The age at death ranged from 0 to 109
years with a median of 69 years (mean = 66.9 years, SD 6 14.6);
77.1% were living in other cities than state capitals, but only
32.3% died there. This means that a considerable number of
Chagas’ disease patients did not live in the capitals, but died
there.
Standardized specific mortality rates
Trends of standardized specific mortality rates, stratified by
Brazilian regions, are shown in Figure 1. Nationwide standardized
mortality rates related to Chagas’ disease reduced gradually from
1999 to 2007 by 26.4%, from 3.78 to 2.78 deaths/100,000
inhabitants (Figure 1). Chagas as underlying cause of death
decreased by 33.2%, from 3.28 to 2.19 deaths/100,000 inhabi-
tants. On the other hand, there was a relative increase by 20.4% of
the rate of associated causes of death, from 0.49 to 0.59 per
100,000 inhabitants between 1999 and 2007.
There were distinct regional patterns. The standardized
mortality rates were highest in the Central-West region, with
rates ranging from 15.23 in 1999 to 9.46 in 2007, a decrease of
37.9%. Polynomial regression shows that during the study period
this decrease was linear with a significantly high R2 value of 82%
(Table 1). Southeast and South regions showed a decrease of
28.8% and 41.8%, respectively (Figure 1). In contrast, mortality
rates increased significantly during the study period in the
Northeast region. The North presented the lowest coefficients,
with a stabilization (Figure 1, Table 1).
Proportional mortality rates
Proportional mortality rates over time, stratified by Brazilian
regions, are shown in Figure 2. Similar to specific rates, the
inclusion of multiple causes of death as compared to underlying
causes increased mortality rate by 20% (0.50% vs. 0.60%). There
was a progressive decrease of proportional mortality as the
underlying cause in Brazil, from 0.53% to 0.45% (15% decline),
but an increase of mortality as associated cause, from 0.08% to
0.14% (75% increase), resulting in an overall stabilization of
proportional mortality considering multiple causes of death i.e. all
mentions (Figure 2). The Central-West showed highest propor-
tional mortality among regions (2.17%), with a significant linear
decreasing trend of multiple causes, from 2.28% to 1.90% (19.5%,
R2 = 84%) between 1999 and 2007 (Figure 2, Table 1). In
contrast, there was a significant increase in the Northeast of 38.5%
(R2 = 82%). The three other regions showed stabilization of
proportional mortality (Table 1, Figure 2).
Factors associated with mortality related to Chagas’
disease
Bivariable analysis of variables associated with Chagas’ disease
as a multiple cause of death is presented in Table 2. All variables
available from death certificates were significantly associated with
Chagas mortality. Highest relative risks were found in older age
groups and those residing in the Central-West. The result of
logistic regression is depicted in Table 3. Similarly, age $30 years
and residence in one of the three high risk states maintained
important independent risk factors for death by Chagas’ disease.
Discussion
We performed the first nationwide population-based study on
Chagas mortality in Brazil considering multiple causes of death,
and provided a comprehensive overview of mortality associated
with Chagas’ disease and trend over time. The data show that
Chagas’ disease is still a public health problem in the country. In
general, mortality indicators tended to decline, but there were
different patterns between regions. Advanced age and region of
residence were identified as important risk factors for death by
Chagas’ disease. The presence of Chagas’ disease as one of the
leading causes of death among elderly in Brazil indicates that the
consequences of infection acquired in the past are still present for a
significant portion of this population [17].
Chagas Mortality in Brazil
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A previous Brazilian study using deaths from Chagas’ disease
as the underlying cause between 1981 and 1998 found a 44.4%
decrease in mortality rates due to Chagas’ disease in 1981–1983
as compared to 1996–1998, and described similar regional
patterns [18]. The high risk of death in Minas Gerais and Goia´s
states is consistent with areas of high endemicity and vector
transmission in previous decades, as reflected by the percentage
of infection and infestation observed in entomological and
serological surveys performed in 1975–1983 [19] and 1975–
1980 [20], respectively. The high mortality rates in the Federal
District can be explained by intense migration of rural
populations from endemic areas [18,21]. In fact, about 1/5 of
migrants in the Federal District come from rural endemic areas
[21]. This scenario highlights future challenges and the need for
continued disease surveillance of main transmission routes in
these endemic regions [19,22], but also for new control strategies
including oral transmission in the Amazon region and secondary
vectors such as Triatoma brasiliensis in the Northeast region
[18,19,23]. In addition to these measures, adequate access to
health services and social assistance to the many chronic chagasic
patients should be guaranteed [22].
Regional differences of the number of deaths due to Chagas’
disease reflect how effective the measures were adopted for the
control of vector transmission and transfusion in the past, but also
may be explained by other factors: transmission will need the
presence of a suitable vector; population immigration of infected
people will influence transmission dynamics; and there is unequal
recognition of the disease, quality of care and diagnostic capacity
in the different regions [24]. This is exemplified by the elimination
of transmission of Chagas’ disease via the main vector T. infestans
which is not frequent in the North and Northeast and thus did not
have a considerable impact on transmission dynamics in these two
regions [18,22]. This indicates that control and primary and
secondary prevention of Chagas’ disease in the North and
Figure 1. Standardized mortality rates related to Chagas’ disease in Brazil and regions, 1999 to 2007.
doi:10.1371/journal.pntd.0001508.g001
Table 1. Trends of mortality indicators related to Chagas’
disease, Brazil and regions, from 1999 to 2007.
Indicator Model* R2** p Trend
Standardized specific mortality rate
Brazil Y = 3.3720.076x 0.63 0.011 Descending
North Y = 0.79+0.011x 0.15 0.309 Stabilization
Northeast Y = 2.18+0.047x+0.013x2 0.64 0.047 Crescent
Southeast Y = 3.9020.119x 0.66 0.007 Descending
South Y= 1.2520.045x 0.52 0.028 Descending
Central-West Y = 12.9520.547x 0.82 0.001 Descending
Proportional mortality rate
Brazil Y = 0.6120.003x 0.42 0.059 Stabilization
North Y = 0.14+0.003x 0.28 0.146 Stabilization
Northeast Y = 0.41+0.011x+0.004x2 0.82 0.006 Crescent
Southeast Y = 0.6720.006x 0.40 0.069 Stabilization
South Y= 0.2220,005x 0.42 0.058 Stabilization
Central-West Y = 2.1820,064x 0.84 0.001 Descending
*Model: y = standardized mortality rates (per 100 000 inhabitants) or
proportional mortality related to Chagas’ disease, considering multiple causes
of death, x = year of death - year average of the period studied (2003).
**R2 = coefficient of determination.
doi:10.1371/journal.pntd.0001508.t001
Chagas Mortality in Brazil
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Northeast has been neglected, resulting in the emergence of new
cases and constant or even increasing mortality rates [25].
The fact that Chagas’ disease is mostly a slowly progressive and
chronic disease and that most deaths are related to an infection
acquired many years earlier suggests that the number of new cases
in the Northeast may have remained constant or even increased
over years. Possible difficulties in controlling secondary vector
species such as T. brasiliensis and Triatoma pseudomaculata, along with
oral and congenital transmission may be contributing factors for
the maintenance of T. cruzi in the Northeast region [25]. Only a
small fraction of deaths were caused by acute Chagas’ disease, with
highest figures in the North region. Interestingly, deaths due to
acute disease were increasing during the study period. In fact, in
the Amazon region the majority of new cases is caused by oral
transmission often leading to acute disease, mainly through the
consumption of unpasteurized natural products (such as the palm
products ac¸ai and bacaba juice), and an increased number of
outbreaks of acute disease has been reported in recent years [26].
Our data further suggest that with the elimination of T. infestans as
the main vector in the country, there is a need to develop
sustainable control methods to reduce the chance of occurrence of
cases directly dependent on secondary transmission by other
vectors [9] and new strategies to control emerging oral
transmission in the Amazon region [26].
Similar to previous studies, our data show that males and
advanced age groups were at higher risk for death related to
Chagas’ disease [14,21,24]. However, our results did not provide
sufficient evidence for the association between males and Chagas
mortality. Whereas in bivariable analysis male gender appeared to
be protective, in multivariable analysis being male was a risk factor
for mortality. This may be caused by the fact that male sex per se is
not a risk factor, but gender-specific behavior patterns causing a
higher prevalence in males, besides social, cultural and behavioral
differences between populations studied [27]. Rassi Jr. et al. [28]
describe a controversy about the prognostic value of male
mortality from Chagas’ disease, shown to be associated with a
worse prognosis in some studies [29,30], but that this finding was
not replicated in others [31–34]. However, most studies involved
restricted subgroups, in contrast to our data.
The highest Chagas death rates in the older age groups
corroborates previous studies [14,21,24] and confirms that there is
a marked tendency of aging of chagasic patients. This transition
can be explained mainly due to a cohort effect, a result of exposure
to infection with T. cruzi in the past [35], considering that
transmission routes of Chagas’ disease (vector-borne and blood
transfusion) have been widely controlled in Brazil [9,36]. The
decrease in early mortality has also been attributed to reduced
reinfection rates, leading to reduced severity of clinical signs of
infection [12,14] with consequently longer survival of patients
[37]. Elderly patients with Chagas’ disease are a particularly
vulnerable population, considering the harmful effects of a
combination of Chagas’ disease and other chronic degenerative
diseases [17]. The frequent association of chronic disease causes
significant demand for health services and medications that
predispose to numerous risks, whereas the association between
Chagas’ disease and other chronic diseases may increase mortality
and worsen the quality of life of those who are in such an
unfavorable condition [17].
The risk of death due to Chagas’ disease was higher among
blacks and mixed race compared to the white population,
Figure 2. Proportional mortality related to Chagas’ disease in Brazil and regions, from 1999 to 2007.
doi:10.1371/journal.pntd.0001508.g002
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www.plosntds.org 5 February 2012 | Volume 6 | Issue 2 | e1508
indicating social disparities in the determination of death related to
Chagas’ disease. This fact corroborates the findings of Gonc¸alves
et al. [34] that during a follow-up of a cohort of chronic chagasic
patients from an endemic area found that different races or black
color were poor prognostic factors for mortality due to Chagas’
disease. However, in more than 10% of death certificates this
information was missing, limiting the validity and reliability of this
result. As there were only 54 deaths reported in indigenous people
in our study, no further conclusions can be made regarding this
subgroup.
Our data also point to an important topic regarding notification of
Chagas’ disease. Historically, only acute cases are subject to
compulsory notification, reflecting the focus of control actions against
Chagas’ disease as an acute condition and on reduction of transmission.
The Brazilian Ministry of Health has been discussing compulsory
notification of chronic forms, considering the burden of chronic disease
in the country and the fact that reactivation of Chagas’ disease in the
presence of HIV infection is considered an AIDS-defining condition in
Brazil [38]. Our study will provide further evidence for the need of
introduction of chronic forms as a notifiable disease.
Table 2. Bivariable analysis of factors associated with death caused by Chagas’ disease, Brazil 1999–2007.
Variables
Death from Chagas’
disease RR 95% confidence interval P value
n %
Gender*
Female 23,172 0.622 Ref.
Male 30,748 0.596 0.96 0.94–0.97 ,0.001
Age group (years)*
,15 118 0.016 Ref.
15–29 815 0.128 7.59 6.25–9.20 ,0.001
30–39 2,333 0.436 25.76 21.41–31.00 ,0.001
40–49 5,783 0.746 43.93 36.61–52.71 ,0.001
50–59 10,929 1.047 61.44 51.25–73.66 ,0.001
60–69 13,686 0.980 57.60 48.05–69.04 ,0.001
70 or more 20,214 0.536 31.67 26.43–37.95 ,0.001
Age ,30 years*
Yes 933 0.069 Ref.
No 52,945 0.704 10.03 9.40–10.70 ,0.001
Race/Color*
Caucasian 25,067 0.531 Ref.
Indigenous 54 0.268 0.50 0.39–0.66 ,0.001
Yellow 344 0.470 0.89 0.80–0.98 0.026
Black 5,341 0.879 1.65 1.60–1.69 ,0.001
Brown 16,017 0.677 1.27 1.25–1.30 ,0.001
Region of residence
North 676 0.144 Ref.
South 3,165 0.223 1.54 1.42–1.68 ,0.001
Northeast 9,618 0.435 3.00 2.78–3.25 ,0.001
Central-West 11,533 2.213 15.01 13.90–16.22 ,0.001
Southeast 28,938 0.677 4.66 4.32–5.03 ,0.001
Federal Units
Other states 30,038 0.391 Ref.
Minas Gerais, Goia´s and Federal
District
23,892 1.952 4.91 4.82–4.99 ,0.001
Residence in state capital
Yes 12,371 0.544 Ref.
No 41,559 0.628 1.15 1.13–1.18 ,0.001
Occurrence in state capital
Yes 36,524 0.614 1.04 1.02–1.06 ,0.001
No 17,406 0.591 Ref.
*Data not available in all cases.
Total number of deaths: 8,942,217.
doi:10.1371/journal.pntd.0001508.t002
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Our study contains some limitations. The number of Chagas-
related deaths may have been underreported, despite the
important progress over the period under study both in the
coverage of the Mortality Information System (SIM), and the
quality of information on causes of deaths. Quality of data may
also vary between regions in the country [14]. We included
multiple causes of deaths, i.e. the mention of Chagas’ disease in any
field rather than only the underlying cause, to reduce this error.
The sociodemographic conditions, such as race/color, education
and usual occupation, considered as possible factors predictive of
mortality associated with Chagas’ disease, showed a considerable
proportion of unknown data. Despite these limitations, we
consider the results of this study of high validity and highly
representative, since all death certificates during the period 1999
to 2007 were included in Brazil, a country of continental
dimensions.
Our data show that mortality rates increased by 21% when
multiple causes of death were considered, as compared to
underlying causes of death. In fact, other authors have highlighted
previously the importance of not only including underlying causes
in mortality statistics, to better reflect the true epidemiology of
Chagas’ disease [14,39].
We conclude that the wealth of information provided by the
analysis of mortality from multiple causes contributed to the
identification of the epidemiological situation of mortality
associated with Chagas’ disease and to predict future trends.
Thus, our study provides comprehensive and reliable information
for planning and evaluation of control measures of Chagas’ disease
in Brazil. In addition to control measures against transmission of
disease, one of the main challenges is the obvious need to improve
clinical care and surgery, ensuring adequate attention to the large
number of cases Chagas’ disease that accumulated over the last
decades.
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